Localized Prostate Cancer Treatment
How MRI use affects management of localized prostate cancer and the nuances of focal therapy are two of the hot topics in localized prostate cancer at this year’s meeting, according to Leonard G. Gomella, MD, professor and chairman of urology at Thomas Jefferson University, Philadelphia.
“The robot frenzy seems to be dying down and the interest in focal therapy seems to be the flavor of this year’s group of AUA papers,” Dr. Gomella said.
Here are Dr. Gomella's abstract picks in localized prostate cancer treatment:
MP47-10: MRI use alters prostate cancer management patterns: Treatment trends in the image-guided biopsy era.
Joseph A. Baiocco
MP70-03: Clinical performance of multi parametric magnetic resonance imaging in the follow-up of partial gland ablation for prostate cancer
MP70-05: Defining the index lesion for salvage partial gland ablation after radiation therapy for localized prostate cancer
MP70-06: Predicting oncological control following focal ablation (FA) of prostate cancer (PCa)
MP70-10: New approach to focal therapy of localized prostate cancer with “fusion” integrated path and high intensity focused ultrasound (HIFU): Initial experience
MP70-12: Predicting extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer
MP93-16: Impact of obesity on prostate cancer recurrence after radical prostatectomy
MP93-19: Prostate MRI prior to prostatectomy does not impact surgical outcomes
PD10-09: Effect of dehydrated human amnion/chorion membrane allograft on urinary continence following robot-assisted radical prostatectomy
PD51-11: Pathological findings at radical prostatectomy after initial active surveillance in low-risk prostate cancer patients. Did we miss the chance to cure?